Status:
COMPLETED
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
Lead Sponsor:
Allergan
Conditions:
Hypotrichosis
Eligibility:
FEMALE
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine patient satisfaction with LATISSE® treatment for increasing eyelash prominence.
Eligibility Criteria
Inclusion
- Have inadequate eyelashes
- Never used prescription eyelash growth products
Exclusion
- No visible eyelashes
- Permanent eyeliner or eyelash implants
- Semi-permanent eyelash tint, dye, or extensions within 3 months
- Over-the-counter eyelash growth products within 6 months
- Any disease, infection or abnormality of the eye or area around the eye
- Eye surgery within 3 months, or the anticipated need for eye surgery during the study
- Unable or unwilling to keep contact lenses out during drug application and for 30 minutes after application
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT01448525
Start Date
October 1 2011
End Date
April 1 2012
Last Update
May 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Coral Gables, Florida, United States